Home   Search   Browse   Statistics   User guide   FAQs   Post question   Download   Process data  
Search results for the GEO ID: GSE38749
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM949009
GPL570
primary tumor 51.17 months survival primary tumor age (y): 88 gender: female histological type: Intestinal tumor stage (ajcc): IIIa time (months) overall survival: 51.17 status: alive tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949010
GPL570
primary tumor 64.83 months survival primary tumor age (y): 75 gender: female histological type: Mixed tumor stage (ajcc): IIIa time (months) overall survival: 64.83 status: alive tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949011
GPL570
primary tumor 58.23 months survival primary tumor age (y): 44 gender: male histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 58.23 status: alive tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949012
GPL570
primary tumor 58.77 months survival primary tumor age (y): 61 gender: male histological type: Intestinal tumor stage (ajcc): IIIb time (months) overall survival: 58.77 status: alive tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949013
GPL570
primary tumor 53.1 months survival primary tumor age (y): 54 gender: female histological type: Diffuse tumor stage (ajcc): III time (months) overall survival: 53.1 status: alive tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949014
GPL570
primary tumor 24.5 months survival primary tumor age (y): 54 gender: female histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 24.5 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949015
GPL570
primary tumor 33.57 months survival primary tumor age (y): 89 gender: male histological type: Diffuse tumor stage (ajcc): IIIb time (months) overall survival: 33.57 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949016
GPL570
primary tumor 22.4 months survival primary tumor age (y): 75 gender: female histological type: Intestinal tumor stage (ajcc): III time (months) overall survival: 22.4 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949017
GPL570
primary tumor 13.6 months survival primary tumor age (y): 41 gender: male histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 13.6 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949018
GPL570
primary tumor 3.67 months survival primary tumor age (y): 38 gender: male histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 3.67 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949019
GPL570
primary tumor 12.93 months survival primary tumor age (y): 65 gender: male histological type: Intestinal tumor stage (ajcc): III time (months) overall survival: 12.93 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949020
GPL570
primary tumor 13.1 months survival primary tumor age (y): 65 gender: male histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 13.1 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949021
GPL570
primary tumor 17.3 months survival primary tumor age (y): 50 gender: male histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 17.3 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949022
GPL570
primary tumor 4.37 months survival primary tumor age (y): 65 gender: female histological type: Diffuse tumor stage (ajcc): IIIa time (months) overall survival: 4.37 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
GSM949023
GPL570
primary tumor 4.27 months survival primary tumor age (y): 58 gender: male histological type: Diffuse tumor stage (ajcc): IIIb time (months) overall survival: 4.27 status: death tissue: gastric cancer tumor Gene expression data from gastric cancer of patient undergoing gastrectomy as a primary treatment
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes